ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
21.042,00
0,18%
S&P 500
6.046,07
0,82%
Dow Jones
43.935,72
1,03%
Euro vs US Dollar
1,04334
0,12%
Bitcoin
107.000,00
4,87%
Pepperstone
Advertisement
Registration Strip Icon for alerts Registrieren Sie sich für Echtzeit-Benachrichtigungen, benutzerdefinierte Portfolios und Marktbewegungen.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. NASDAQ

  6. Clene Inc (CLNN) Börsenkurse

Clene Inc

Clene Inc (CLNN)

NASDAQ
4,80
0,01
( 0,21% )
Aktualisiert: 19:37:47
Verzögert um 15 Minuten

Echtzeit-Diskussionen und Handelsideen: Handeln Sie mit Zuversicht mit unserer leistungsstarken Plattform.

Premium

Wichtige Statistiken und Details

Current Price
4,80
Gebot
4,82
Fragen
4,92
Volumen
38.494
4,7682 Tagesbereich 4,99
3,8181 52-Wochen-Bereich 11,00
Marktkapitalisierung
38,303M
Handelsende
4,79
Handelsbeginn
4,97
Letzte Trade
5
@
4.8339
Letzter Handelszeitpunkt
19:39:19
Finanzvolumen
US$ 187.096
VWAP
4,8604
Durchschnittliches Volumen (3 Mio.)
83.005
Ausgegebene Aktien
7.979.726
Dividendenrendite
-
Kurs-Gewinn-Verhältnis
-0,78
Gewinn pro Aktie (EPS)
-6,2
Erlöse
654k
Nettogewinn
-49,5M

Über Clene Inc

Clene Inc is a clinical-stage pharmaceutical company pioneering the discovery, development, and commercialization of novel clean-surfaced nanotechnology (CSN) therapeutics. It is focused on the development of therapeutics for neurodegenerative diseases. Its reportable segments: (1) the development a... Clene Inc is a clinical-stage pharmaceutical company pioneering the discovery, development, and commercialization of novel clean-surfaced nanotechnology (CSN) therapeutics. It is focused on the development of therapeutics for neurodegenerative diseases. Its reportable segments: (1) the development and commercialization of novel clean-surfaced nanotechnology therapeutics (Drugs, and (2) the development and commercialization of dietary supplements (Supplements). Mehr anzeigen

Sektor
Pharmaceutical Preparations
Branche
Pharmaceutical Preparations
Website
www.clene.com
Hauptsitz
Dover, Delaware, USA
Gegründet
-
Clene Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker CLNN. The last closing price for Clene was US$4,79. Over the last year, Clene shares have traded in a share price range of US$ 3,8181 to US$ 11,00.

Clene currently has 7.979.726 shares in issue. The market capitalisation of Clene is US$38,22 million. Clene has a price to earnings ratio (PE ratio) of -0.78.

CLNN Neueste Nachrichten

Weitere Nachrichten

Form 4 - Statement of changes in beneficial ownership of securities

19 August 2024
Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities

19 August 2024
Edgar (US Regulatory)

IBN Announces Latest Episode of The BioMedWire Podcast featuring Rob Etherington, CEO of Clene Inc.

LOS ANGELES, Aug. 08, 2024 (GLOBE NEWSWIRE) -- via IBN – IBN, a multifaceted communications organization engaged in connecting public companies to the investment community, is pleased to...

08 August 2024
GlobeNewswire Inc.

Form 8-K - Current report

07 August 2024
Edgar (US Regulatory)

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

07 August 2024
Edgar (US Regulatory)

Form 8-K - Current report

06 August 2024
Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities

30 Juli 2024
Edgar (US Regulatory)

Form 8-K - Current report

26 Juli 2024
Edgar (US Regulatory)

Form 8-K - Current report

11 Juli 2024
Edgar (US Regulatory)

Form 8-K - Current report

09 Juli 2024
Edgar (US Regulatory)
Zeitraum †ÄnderungÄnderung %HandelsbeginnHochNiedrigDurchsch. VolumenVWAP
1-0.14-2.834008097174.945.14.75340654.83913172CS
40.081.694915254244.726.28994.5725515.28332066CS
12-0.97-16.81109185445.776.53.85830054.8105185CS
260.4710.85450346424.336.963.81811062855.2808664CS
52-4.8-509.6113.81814219507.3591617CS
156-48-90.909090909152.8102.63.818153594729.15964056CS
260-186.2-97.4869109948191356.43.818146464553.9536248CS

CLNN - Frequently Asked Questions (FAQ)

What is the current Clene share price?
The current share price of Clene is US$ 4,80
How many Clene shares are in issue?
Clene has 7.979.726 shares in issue
What is the market cap of Clene?
The market capitalisation of Clene is USD 38,22M
What is the 1 year trading range for Clene share price?
Clene has traded in the range of US$ 3,8181 to US$ 11,00 during the past year
What is the PE ratio of Clene?
The price to earnings ratio of Clene is -0,78
What is the cash to sales ratio of Clene?
The cash to sales ratio of Clene is 59,02
What is the reporting currency for Clene?
Clene reports financial results in USD
What is the latest annual turnover for Clene?
The latest annual turnover of Clene is USD 654k
What is the latest annual profit for Clene?
The latest annual profit of Clene is USD -49,5M
What is the registered address of Clene?
The registered address for Clene is 3500 S DUPONT HWY, KENT, DOVER, DELAWARE, 19901
What is the Clene website address?
The website address for Clene is www.clene.com
Which industry sector does Clene operate in?
Clene operates in the PHARMACEUTICAL PREPARATIONS sector

Beweger

Alle Anzeigen
  • Volumen
  • % Tops
  • % Flops
SymbolPreisVol.
USEGUS Energy Corp
US$ 4,5201
(94,83%)
90,84M
ASSTAsset Entities Inc
US$ 0,8486
(82,69%)
242,6M
GCTKGlucoTrack Inc
US$ 0,1226
(44,41%)
452,59M
DOGZDogness International Corporation
US$ 25,84
(42,76%)
1,32M
RGTIRigetti Computing Inc
US$ 13,36
(35,91%)
177,21M
GOEVCanoo Inc
US$ 0,3522
(-73,91%)
34,7M
HEPAHepion Pharmaceuticals Inc
US$ 0,296
(-36,89%)
621,73k
ORKTOrangeKloud Technology Inc
US$ 0,7532
(-32,75%)
6,19M
WNWMeiwu Technology Company Ltd
US$ 0,2653
(-27,81%)
8,53M
FTAIFTAI Aviation Ltd
US$ 83,0882
(-26,06%)
13,59M
GCTKGlucoTrack Inc
US$ 0,1227
(44,52%)
454,09M
CRKNCrown Electrokinetics Corporation
US$ 0,1194
(-4,48%)
355,81M
ASSTAsset Entities Inc
US$ 0,8486
(82,69%)
243,09M
RGTIRigetti Computing Inc
US$ 13,365
(35,96%)
177,37M
RIMEAlgorhythm Holdings Inc
US$ 0,035
(-15,87%)
145,98M

Foren

Foren anzeigen
Keine Diskussionen Gefunden.
Neuen Thread Erstellen

Kürzlich von Ihnen besucht

NASDAQ
CLNN
Clene
TG
A3LJCD
Grenke
TG
EF8D
European Financial Stabi...
TG
A3KM08
Eaton Capital Unlimited
BOV
G1LL34
Globe Life
BIT
P10MP5
Bnp Paribas Issuance
TG
A3K1M1
National Bank of Canada
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2025 ADVFN PLC - Alle Rechte vorbehalten